Despite improvements in management, S. aureus remains a major cause of mastitis. Its chronic and destructive nature often leads to premature culling and ample loss of revenue. Additional help was sought in the form of a mastitis vaccine to overcome this challenge. The study investigated the ability of a mastitis vaccine to reduce new intra-mammary infections (IMI) with Staphylococcus aureus (S. aureus), improve bacterial cure, and reduce the duration of IMI and to investigate its effect on milk somatic cell count.
A controlled field study investigating the effects of a mastitis vaccine in a Staphylococcus aureus positive dairy herd
Inactivated vaccine against enterotoxaemia, sudden death, blackleg and black disease, in injectable suspension
An innovative service based on data analysis that facilitates decision-making in Cattle
This online calculator will allow you to know your farm costs, find out the costs associated with clinical and subclinical mastitis and analyse the production losses associated with mastitis
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
Discover HIPRA’s pioneer programme to rear animals without the use of preventive antibiotics or coccidiostats
HIPRA has specially developed several online tools to support veterinarians and other Animal Health professionals in their daily work.
Subscribe to our newletters and receive the latest news on Animal Health delivered straight to your inbox